Biomarkers · Chemical
gASCA
- Primary unit
- units
- LOINC codes
- 47321-5
- Tests that measure gASCA
- Quest Diagnostics 3, Labcorp 2
Ranges
Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ
Quest Diagnostics, Saccharomyces cerevisiae Antibodies (ASCA) (IgG) 10294
| Population | Interval |
|---|---|
| Value | Interpretation |
| ≤20.0 | Negative |
| 20.1-29.9 | Equivocal |
| ≥30.0 | Positive |
Quest Diagnostics, Saccharomyces cerevisiae Antibodies (ASCA) (IgG, IgA) 17609
| Population | Interval |
|---|---|
| ≤20.0 U | Negative |
| 20.1-29.9 U | Equivocal |
| ≥30.0 U | Positive |
| ≤20.0 U | Negative |
| 20.1-24.9 U | Equivocal |
| ≥25.0 U | Positive |
Tests
Check the catalog code, specimen, method and preparation for every test that measures gASCA. Select up to five tests to compare them side by side.
Quest Diagnostics 3 tests
Single-analyte tests
Saccharomyces cerevisiae Antibodies (ASCA) (IgG, IgA) 17609
Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
Saccharomyces cerevisiae Antibodies (ASCA) (IgG) 10294
Serum · Fasting not stated · Turnaround Set up: Wed (p.m.); Report available: 9 days
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
Panels that include this biomarker
Inflammatory Bowel Disease Differentiation Panel 16503
3 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
- Reference notes
- ANCA Screen Negative P-ANCA Titer <1:20 C-ANCA Titer <1:20 Atypical P-ANCA Titer <1:20 Myeloperoxidase Antibody <1.0 AI No antibody detected ≥1.0 AI Antibody detected Proteinase-3 Antibody <1.0 AI No antibody detected ≥1.0 AI Antibody detected Saccharomyces cerevisiae Ab (IgG) ≤20.0 U Negative 20.1-29.9 U Equivocal ≥30.0 U Positive Saccharomyces cerevisiae Ab (IgA) ≤20.0 U Negative 20.1-24.9 U Equivocal ≥25.0 U Positive
Labcorp 2 tests
Panels that include this biomarker
Crohn's Disease Prognostic Profile 162020
4 analytes · Serum · Fasting not stated · Turnaround 3 - 7 days
Labcorp catalog pageMethod and collection
- Method
- Enzyme immunoassay (EIA)
Inflammatory Bowel Disease (IBD) Expanded Profile 162045
5 analytes · Serum · Fasting not stated · Turnaround 4 - 7 days
Labcorp catalog pageMethod and collection
- Method
- Enzyme immunoassay (EIA) for ACCA, ALCA, AMCA, gASCA; indirect fluorescent antibody (IFA) for atypical pANCA
- Reference notes
- When the only positive marker is pANCA, the interpretive comment on the report will read: "Suggestive of ulcerative colitis." When only one of ACCA, ALCA, AMCA, or gASCA is positive and pANCA is negative, the interpretive comment will read: "Suggestive of Crohn's disease. Pattern is not conclusive for disease behavior risk stratification." When only one of ACCA, ALCA, AMCA, or gASCA is positive and pANCA is positive, the interpretive comment will read: "Suggestive of inflammatory bowel disease. Pattern is not conclusive for any specific disease form." When any two of ACCA, ALCA, AMCA, or gASCA are positive and pANCA is positive or negative, the interpretive comment will read: "Suggestive of Crohn's disease with high risk of aggressive disease behavior (development of strictures or fistulae)." When any three or more of ACCA, ALCA, AMCA, or gASCA are positive and pANCA is positive or negative, the interpretive comment will read: "Suggestive of Crohn's disease with the very high risk of aggressive disease behavior (development of strictures or fistulae)." When all markers are negative, the interpretive comment on the report will read: "Pattern is not suggestive of inflammatory bowel disease."
0 of 5 tests selected
Pick one moreSources
2 tests: codes, specimens, methods, preparation and reference intervals.
Quest Diagnostics test catalog
3 tests: codes, specimens, methods, preparation and reference intervals.
LOINC 47321-5
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for gASCA
Registered studies that measure gASCA, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.